What is Driving the Growth of the Scleroderma Therapeutics Market?

What is Driving the Growth of the Scleroderma Therapeutics Market? The global scleroderma therapeutics market is gaining traction due to a rise in disease prevalence, advances in research, and growing awareness about autoimmune disorders. In 2024, the market was valued at USD 2.04 billion, and it is expected to reach USD 3.72 billion by 2034, growing at a CAGR of 6.20% during the forecast...

909